Across TCGA pan-cancer cohorts, TRIM49D1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated TRIM49D1 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher TRIM49D1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRIM49D1 expression acts as an unfavorable survival marker.
BLCA, KIRC, and THYM are the cancer types where TRIM49D1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.